# Residual Platelet Activity In Advanced Peripheral Artery Disease

Study · id `cardio:ct-nct01627431` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01627431](<https://clinicaltrials.gov/study/NCT01627431>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01627431

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 410 participants.

## Technical summary

Registry record NCT01627431. Allocation not applicable; no masking; primary purpose basic science. Start 2012-07 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose basic science
- Phase: Phase 4
- Enrolled: 410 participants (planned count; ClinicalTrials.gov record NCT01627431, source copy `cardio:ctgov-nct01627431-2012-11-28`, retrieved 2026-10-31)
- Start date: 2012-07 (registry gives no type) (ClinicalTrials.gov record NCT01627431, source copy `cardio:ctgov-nct01627431-2012-11-28`, retrieved 2026-10-31)
- Primary completion: 2014-07 (anticipated) (ClinicalTrials.gov record NCT01627431, source copy `cardio:ctgov-nct01627431-2012-11-28`, retrieved 2026-10-31)
- Completion: 2015-07 (anticipated) (ClinicalTrials.gov record NCT01627431, source copy `cardio:ctgov-nct01627431-2012-11-28`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT01627431, source copy `cardio:ctgov-nct01627431-2012-11-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01627431-2012-11-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Residual Platelet Activity In Advanced Peripheral Artery Disease
- Acronym: TRAIANO
- Condition: Peripheral Arterial Disease
- Intervention (Drug): Acetylsalicylic acid
- Intervention (Drug): Clopidogrel
- Lead sponsor: University of Roma La Sapienza
- Lead sponsor class: OTHER
- Collaborator: University of Florence
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)
- Registry lists this organization as a collaborator: University of Florence (`cardio:org-university-of-florence`)

## Provenance

Content hash: 80b412227f162f9659824fc743a2c63804d50c0eb809077576c2f2e84c0ba402
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
